跳至主要内容
临床试验/CTRI/2025/08/092777
CTRI/2025/08/092777尚未招募不适用

A Clinical Comparative Study To Evaluate The Effect Of Vaasadi Kwatha And Triphala Kwatha In The Management Of Vataja Pandu vis-à-vis Iron Deficiency Anemia

Dr Akshatha1 个研究点 分布在 1 个国家目标入组 40 人开始时间: 2025年8月17日最近更新:

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
40
试验地点
1
主要终点
Improvement in laboratory parameters which includes,CBP,SERUM IRON

研究概览

简要总结

This is a postgraduate academic clinical study conducted  to compare the Clinical effect of Vaasadi kwatha and Triphala kwatha in the Management of Vataja Pandu with special reference to iron deficiency anemia.

vataja pandu is a condition in which  there is  vaivarnata, dourbalya, shrama, hridaya spanadana, shwasa etc symptoms which affects the overall health and quality of life.

In Current study two classical ayurvedic formulations are being compared in efficacy, for the treatment of Vataja Pandu. The two formulations being Triphala Kwatha and Vaasadi Kwatha.

The primary objective of this clinical study is to assess and compare the lab parameters signs and symotoms in the condtion of Vataja Pandu.

Here the participants will be randomly allocated into two groups. The treatment will be given for 30 Days followed by assessment on 15th and 30th day. Post study follow up will be conducted on 90th day.

The result of this clinical study will help us to evaluate the comparative efficacy of the above mentioned drugs in Vataja Pandu / Iron Deficiency Anemia.

研究设计

研究类型
Interventional
分配方式
Coin toss, Lottery, toss of dice, shuffling cards etc
盲法
None

入排标准

年龄范围
18.00 Year(s) 至 60.00 Year(s)(—)
性别
All

入选标准

  • Patients presenting with the classical signs and symptoms of vataja panduroga as per classical text and vis-à-vis Iron deficiency anemia in modern science.
  • Patients aged between 18 to 60years.
  • Patients of either gender.
  • Hb% ranging from ( in men 7-13gm/dl and in women 7-12 gm/dl).

排除标准

  • Patients having Systemic and Infectious Diseses.
  • pregnant and lactating mother.
  • patient with Genetic ,Congenital,Acute blood loss,Hemolytic disorders and Aplastic Anemia,
  • Hb% Level below 7gm/dl.

结局指标

主要结局

Improvement in laboratory parameters which includes,CBP,SERUM IRON

时间窗: 1st day,15th day,30th day.

次要结局

未报告次要终点

研究者

发起方
Dr Akshatha
申办方类型
Other [self]
责任方
Principal Investigator
主要研究者

Dr Akshatha

Ramakrishna Ayurvedic Medical College, Hospital And Research Centre

研究点 (1)

Loading locations...

相似试验